Back
PubMedNew recommendation

A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome.

Courtwright A, King RA, Vagher J, et al.Clin Genet 2026 · May 2026
Relevance score
5/10
Disease / domain
Short Telomere Syndrome
Source
PubMed
PMID 42219160
Share on LinkedIn

Variant / mechanism

Pathogenic variants in telomere maintenance genes → accelerated shortening transmissible independently of the causal variant

Summary

This manuscript proposes a structured clinical diagnostic framework for Short Telomere Syndrome (STS), distinguishing four groups based on telomere length and phenotypic manifestations. The authors recommend the term STS over TBD (telomere biology disorder) and emphasize a phenotype-based approach: bone marrow, pulmonary, or hepatic involvement, with surveillance tailored to each group. Transmission of telomere length independently of the genetic variant complicates standard genetic counseling.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

STS is chronically under-diagnosed, often confused with idiopathic aplastic anemia or interstitial lung disease of unknown cause. This four-group diagnostic framework is directly applicable in genetics consultations and should be incorporated into management guidelines for these multisystemic conditions.

Why this score?

Clinical impact: 3/3 · Evidence strength: 1/3 · Novelty: 1/2 · Sample size: 0/1 · Publication status: 0/1 → Total: 5/10

Keywords

short telomere syndromeSTSaplastic anemiainterstitial lung diseaseWGSdiagnostic yield
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime